Old Web
English
Sign In
Acemap
>
authorDetail
>
K.‐H. Labs
K.‐H. Labs
Vascular dementia
Psychology
Clinical trial
Propentofylline
Dementia
3
Papers
111
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A 12-Month, Randomized, Placebo-Controlled Trial of Propentofylline (HWA 285) in Patients with Dementia According to DSM III-R
1997
Dementia and Geriatric Cognitive Disorders
Jan Marcusson
Matthias Rother
Barbara Kittner
M Rössner
R J Smith
T Babic
V. Folnegović-Šmalc
H. J. Möller
K.‐H. Labs
Show All
Source
Cite
Save
Citations (81)
30 Problems in performing clinical trials in Alzheimer's disease (AD) and vascular dementia (VaD)
1996
Neurobiology of Aging
B. Kittner
M. Rother
M. Rößner
K.‐H. Labs
F. J. Huff
Show All
Source
Cite
Save
Citations (0)
HWA 285 (Propentofylline)—A New Compound for the Treatment of Both Vascular Dementia and Dementia of the Alzheimer Type
1996
Annals of the New York Academy of Sciences
M. Rother
B. Kittner
K. Rudolphi
M. Rößner
K.‐H. Labs
Show All
Source
Cite
Save
Citations (30)
1